Karyopharm HCP Connect

Karyopharm HCP Connect is designed with the goal to help inform healthcare providers with key information and resources pertaining to the treatment of selinexor in combination with bortezomib and dexamethasone (XVd) in patients with Multiple Myeloma who have received at least one prior therapy. The app provides helpful, easily navigable information about selinexor right at your fingertips. Resources within the app include convenient ways to request a discussion with your peers who have extensive selinexor clinical experience as well as to contact your Karyopharm Medical Representatives; BOSTON (XVd) clinical trial design, XVd efficacy & safety data, XVd dosing and dose modification information, detailed supportive care guidance and access to Med Info FAQs.